Recruiting

Observational Study

Sponsor:

Emory University

Code:

NCT00378924

Conditions

Cardiovascular Disease

Eligibility Criteria

Sex: All

Age: 20+

Healthy Volunteers: Accepted

Study Details

Brief summary:

In the present study, investigators intend to establish a large database of cardiovascular patients. More specifically, investigators will create a database of approximately 12,000 cardiac catheterization and heart failure patients from Emory University Hospital, the Emory Clinic, Emory University Hospital Midtown, Grady Memorial Hospital, Atlanta VA Medical Center, Organized/Planned Community Events in the Atlanta Metropolitan area, held at places of Worship, local Community Centers, shopping Malls, doctor's Offices and Health Clinics and any other miscellaneous locations, e.g. Parks, Leisure centers, Conference centers.

Once the data has been collected, investigators will run a variety of statistical analyses to which will help us to learn more about the factors that cause various cardiovascular diseases such as coronary heart disease, angina, heart failure, hypertension, and stroke. The statistical analyses will also help us to understand how these diseases can be treated more effectively.

By collecting a large amount of data on a large number of cardiovascular patients, investigators will be able to analyze, with a great deal of precision, those factors that influence the onset, course, and treatment of cardiovascular disease. The results of these precise analyses can then be used to help optimize clinical efforts to prevent and treat cardiovascular disease.

Conditions

Cardiovascular Disease

Study ID

NCT00378924

Start date

Dec, 2003

Status verified date

Jun, 2026

Completion date

Apr, 2030

Anticipated

Primary completion date

Apr, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 20+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. All hospital and clinic participants aged 18 years and older
2. Participants with and without active or presumed cardiovascular disease including but not limited to:

1. Coronary Artery Disease
2. Heart Failure and Cardiomyopathies
3. Peripheral Vascular Disease
4. Valve disease
5. Adult Congenital Heart disease
6. Electrophysiological Disorders
3. Any individual aged 18 and above in satisfactory physical health and able to tolerate a blood draw or buccal swab.

Exclusion Criteria:

1. Significant Documented Anemia (Hemoglobin <8 g/dL)
2. Blood transfusions within past 3 weeks
3. Enrollment against doctor recommendation
4. Participant not able to provide consent including but not limited to:

1. Intubated and critically unwell participants
2. Dementia
3. Alzheimer's disease
4. Moderate to severe alcohol or drug abuse
5. Against religious beliefs (e.g. Jehovah's witness)

Study Design

Enrollment

12000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • All cause death [ Time Frame: Continuous ]

Central Contacts and Locations

Central contacts

Ayman J Tahhan, MD

404 712 0168ayman.tahhan@emory.edu

Salman Sher, MD

404 412 0170ssher2@emory.edu

Locations

Emory School Of Medicine

Recruiting

Atlanta, Georgia, United States, 30322

Contacts

Ayman J Tahhan, MD

404 712 0168ayman.tahhan@emory.edu

Salman Sher, MD

404 712 0170ssher2@emory.edu

Principal Investigator:

Arshed A Quyyumi, MD

More Information

Sponsor

Emory University

Last update posted

Jun 29, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Emory University on 2026-06-29.